Human monoclonal antibody against a costimulatory signal...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61P 37/06 (2006.01) A61P 37/08 (2006.01) C07K 16/18 (2006.01) C07K 16/28 (2006.01) C12N 5/10 (2006.01) C12N 5/16 (2006.01) C12N 15/12 (2006.01) C12N 15/63 (2006.01) C12P 21/08 (2006.01) G01N 33/554 (2006.01) G01N 33/58 (2006.01)

Patent

CA 2344086

Immunization of human antibody-producing transgenic mice, which have been created using genetic engineering techniques, with AILIM molecule as an antigen resulted in various human monoclonal antibodies capable of binding to AILIM and capable of controlling a variety of biological reactions (for example, cell proliferation, cytokine production, immune cytolysis, cell death, induction of ADCC, etc.) associated with AILIM-mediated costimulatory signal (secondary signal) transduction. Furthermore, it has been revealed that the human monoclonal antibody is effective to treat and prevent various diseases associated with AILIM-mediated costimulatory signal transduction, being capable of inhibiting the onset and/or advancement of the diseases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Human monoclonal antibody against a costimulatory signal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human monoclonal antibody against a costimulatory signal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibody against a costimulatory signal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1557746

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.